News

Breast reconstruction awareness day & breast cancer awareness month for October

SIU Medicine joins other organizations and families around the country in celebrating National Breast Cancer Awareness Month during October. We're doing our part to spread awareness about this leading type of cancer, including its signs and symptoms, how it's diagnosed and treated, and how you can prevent it. An often overlooked aspect of breast cancer awareness is life after breast cancer surgery. Though a mastectomy can save a woman's life, it can also leave her reeling with unexpected emotions and challenges. For this reason, SIU Medicine encourages our communities to honor another
Trial
Neurology

Roche: A Phase IIB, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of intravenous prasinezumab in participants with early Parkinson's disease

Active not recruiting

This study will evaluate the efficacy, safety, and pharmacokinetics of prasinezumab compared with placebo in patients with early Parkinson's disease (PD).

Contact: Rylee Manka 217-545-1394
Trial
Psychiatry

RECOVER: A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy System as Adjunctive Therapy Versus a No-Stimulation Control in Subjects with Treatment-Resistant Depression

Active recruiting

The RECOVER study is a nationwide clinical trial that has been approved by Medicare to provide additional evidence for the benefits of Vagus Nerve Stimulation (VNS) Therapy.  Vagus Nerve Stimulation Therapy is an FDA-approved device for treating patients with TRD (Treatment Resistant Depression). It is implanted in the left chest area during a short outpatient procedure. The device delivers mild, intermittently pulsed signals to the vagus nerve in the neck that activate various parts of the brain.

Contact: Oladele (Dickson) Owasoyo 217-545-7231
News

SIU Medicine enrolling patients for clinical study to treat depression

SPRINGFIELD, ILLINOIS, October 18, 2021 – Clinical depression affects more than 17 million people in the United States. Among those afflicted, 1 out of 3 has what is called treatment-resistant depression (TRD). Despite medical help, they have been unable to find adequate relief from their symptoms. A new clinical trial at SIU School of Medicine is testing a treatment that could help those with recurring depression. “Depression is a common mental disorder that can become disabling if not treated,” said Jeffrey Bennett, MD, professor of psychiatry at SIU School of Medicine and the principal
News

SIU Medicine enrolling patients for clinical study to treat depression

SPRINGFIELD, ILLINOIS, October 18, 2021 – Clinical depression affects more than 17 million people in the United States. Among those afflicted, 1 out of 3 has what is called treatment-resistant depression (TRD). Despite medical help, they have been unable to find adequate relief from their symptoms. A new clinical trial at SIU School of Medicine is testing a treatment that could help those with recurring depression. “Depression is a common mental disorder that can become disabling if not treated,” said Jeffrey Bennett, MD, professor of psychiatry at SIU School of Medicine and the principal
News

SIU Medicine enrolling patients for clinical study to treat depression

SPRINGFIELD, ILLINOIS, October 18, 2021 – Clinical depression affects more than 17 million people in the United States. Among those afflicted, 1 out of 3 has what is called treatment-resistant depression (TRD). Despite medical help, they have been unable to find adequate relief from their symptoms. A new clinical trial at SIU School of Medicine is testing a treatment that could help those with recurring depression. “Depression is a common mental disorder that can become disabling if not treated,” said Jeffrey Bennett, MD, professor of psychiatry at SIU School of Medicine and the principal
Trial
Neurology

Athira: A Randomized, Placebo-Controlled, Double-Blind, Dose-Ranging Study to Evaluate Safety and Efficacy of ATH-1017 Treatment in Alzheimer’s Dementia Patients

Active recruiting

ATH-1017-AD-201: The purpose of this study is to compare the effects, good or bad, of ATH-1017 on patients with mild to moderate Alzheimer's Disease.

Contact: Stephanie Kohlrus 217-545-3013
Events

Agriculture and Mental Health: Helping In Times of Distress

An Introduction to Helping Skills In this first session, participants will explore elements of a helping/ therapeutic conversation in a 40-minute interactive webinar. Practical application specific to producers and their families will behighlighted, and the webinar will conclude with discussion, questions, and answers. Recognizing Signs of Psychological Distress In the second session, participants will learn to identify typical presentations of depression, anxiety, and suicidality, along with learning triage for suicidal ideation in this 40-minute interactive webinar. Practical application
Events

Agriculture and Mental Health: Helping In Times of Distress

An Introduction to Helping Skills In this first session, participants will explore elements of a helping/ therapeutic conversation in a 40-minute interactive webinar. Practical application specific to producers and their families will behighlighted, and the webinar will conclude with discussion, questions, and answers. Recognizing Signs of Psychological Distress In the second session, participants will learn to identify typical presentations of depression, anxiety, and suicidality, along with learning triage for suicidal ideation in this 40-minute interactive webinar. Practical application
Events

Agriculture and Mental Health: Helping In Times of Distress

An Introduction to Helping Skills In this first session, participants will explore elements of a helping/ therapeutic conversation in a 40-minute interactive webinar. Practical application specific to producers and their families will behighlighted, and the webinar will conclude with discussion, questions, and answers. Recognizing Signs of Psychological Distress In the second session, participants will learn to identify typical presentations of depression, anxiety, and suicidality, along with learning triage for suicidal ideation in this 40-minute interactive webinar. Practical application
Subscribe to Patient